The data show that, after failureof second-line chemotherapy, lung-cancer patients rarely get any added survival time from further treatments and often suffer significant side effects.
By studying the climbers, six of whom reached the summit, the researchers hope to gain insight into heart failure, lung disease and sleep apnea all conditions related to a low-oxygen, or hypoxic, state.